XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2022
Oct. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,417,608 $ 1,432,840
Short-term investments 147,913 147,949
Total cash, cash equivalents and short-term investments 1,565,521 1,580,789
Accounts receivable, net 796,091 568,501
Inventories 211,927 229,023
Prepaid and other current assets 439,130 430,028
Total current assets 3,012,669 2,808,341
Property and equipment, net 483,300 472,398
Operating lease right-of-use assets, net 559,090 493,251
Goodwill 3,842,234 3,575,785
Intangible assets, net 386,446 279,132
Deferred income taxes 670,653 612,655
Other long-term assets 463,695 510,698
Total assets 9,418,087 8,752,260
Current liabilities:    
Accounts payable and accrued liabilities 809,403 741,191
Operating lease liabilities 54,274 79,678
Deferred revenue 1,910,822 1,517,623
Short-term debt 0 74,992
Total current liabilities 2,774,499 2,413,484
Long-term operating lease liabilities 581,273 487,003
Long-term deferred revenue 154,472 136,303
Long-term debt 20,824 25,094
Other long-term liabilities 327,829 391,433
Total liabilities 3,858,897 3,453,317
Redeemable non-controlling interest 38,664 0
Stockholders’ equity:    
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 par value: 400,000 shares authorized; 152,375 and 153,062 shares outstanding, respectively 1,524 1,531
Capital in excess of par value 1,487,126 1,576,363
Retained earnings 5,534,307 4,549,713
Treasury stock, at cost: 4,886 and 4,198 shares, respectively (1,272,955) (782,866)
Accumulated other comprehensive income (loss) (234,277) (49,604)
Total Synopsys stockholders’ equity 5,515,725 5,295,137
Non-controlling interest 4,801 3,806
Total stockholders’ equity 5,520,526 5,298,943
Total liabilities, redeemable non-controlling interest and stockholders’ equity $ 9,418,087 $ 8,752,260